PBAC Stakeholder Meeting - Nitisinone for tyrosinaemia type 1 (February 2015)

Page last updated: 13 March 2015

A stakeholder meeting was held on 4 February 2015 to discuss issues related to a recent submission to the PBAC to list nitisinone (Orfadin®) on the PBS for the treatment of tyrosinaemia type 1. For further information refer to the stakeholder meeting outcome statement.